Key facts
- Aufbau Holdings’s last known valuation is $157.2M (Aug 2025).
- It has raised $37.1M across 4 recorded rounds; the latest was Early Stage VC ($6.1M) in Apr 2025.
- Notable investors include Atlantic Blue Ventures, Center for Life Science Ventures, Cliffdale Investments., Cornell University, Hillside Capital.
- Aufbau Holdings has filed 4 Form Ds with the SEC since 2019, most recently Apr 2025 ($6.1M sold to 8 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Aufbau Holdings
Funding rounds
4 roundsAbout Aufbau Holdings
Operator of a biotechnology company intended to develop novel diagnostics and therapeutics for ophthalmic diseases and cancer. The company conducts research and development on technologies for the detection, monitoring, and treatment of ophthalmic disorders and life-threatening systemic cancers, enabling patients to get better treatment methods.
- Sector
- Healthcare
- HQ
- Dublin, Ireland
- Founded
- 2019
- Website
- aufbauholdings.com/
- Ownership
- Privately Held (backing)
Aufbau Holdings doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aufbau Holdings shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aufbau Holdings in its N-PORT filings yet. We sweep new filings monthly.